跳至主要内容
临床试验/NCT01725906
NCT01725906Unknown4 期

Genotypic Resistance Guided Therapy in the Treatment of Helicobacter Pylori Infection

National Taiwan University Hospital2 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2012年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
450
试验地点
2
主要终点
Eradication rate after third line rescue therapy

研究概览

简要总结

We aimed to compare the efficacy of genotypic resistance guided sequential therapy vs. empiric therapy in the third line therapy. Factors affecting the eradication rates, including the antibiotic resistance, CYP2C19 polymorphism, CagA and VacA status will also be assessed.

详细描述

The primary aim of this study is to compare the regimens selected using either one of the method (1) genotypic resistance guided versus (2) medication history guided therapy. (rather than to compare the efficacy of any drugs).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged greater than 20 years who have persistent H. pylori infection after at least two treatments and are willing to receive third line rescue regimens are considered eligible for enrollment.

排除标准

  • Patients will be excluded from the study if any one of the following criteria is present: (1) children and teenagers aged less than 20 years, (2) history of gastrectomy, (3)gastric malignancy, including adenocarcinoma and lymphoma, (4) previous allergic reaction to antibiotics (Amoxicillin, Klaricid, Cravit) and prompt pump inhibitors (esomeprazole), (5)contraindication to treatment drugs, (6) pregnant or lactating women, (7) severe concurrent disease.

研究组 & 干预措施

Empirical therapy

Active Comparator

selection of antibiotic according to medication history

干预措施: empirical therapy (Drug)

Genotypic resistance guided therapy

Experimental

selection of antibiotics according to genotypic resistance

干预措施: Genotypic resistance guided therapy (Drug)

结局指标

主要结局

Eradication rate after third line rescue therapy

时间窗: 8 weeks

Primary End Point: Eradication rate will be evaluated according to Intent-to-treat (ITT) and per-protocol (PP) analyses. (genotypic resistance versus empirical therapy) Urea breath test will be used to determine the eradication status

次要结局

  • eradication rates in subgroup analysis by antibiotic resistance and regimen(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

National Taiwan University Hospital

Doctor

National Taiwan University Hospital

研究点 (2)

Loading locations...

相似试验